Inovio Pharmaceuticals Inc (INO) — Cash Flow-to-Debt Ratio
Inovio Pharmaceuticals Inc (INO) has a Cash Flow-to-Debt Ratio of -0.28x as of September 2025, meaning its operating cash flow of $-21.57 Million could theoretically repay 0% of its total liabilities ($77.11 Million) in one year. See financial agility of Inovio Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Inovio Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Inovio Pharmaceuticals Inc across 27 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Inovio Pharmaceuticals Inc.
Annual Cash Flow-to-Debt Ratio for Inovio Pharmaceuticals Inc (1998–2024)
Year-by-year debt coverage analysis for Inovio Pharmaceuticals Inc. Check Inovio Pharmaceuticals Inc (INO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.33x | $-104.08 Million | $44.69 Million | ▼ -0.4% |
| 2023 | -2.32x | $-124.37 Million | $53.60 Million | ▼ -35.4% |
| 2022 | -1.71x | $-216.22 Million | $126.17 Million | ▲ +23.5% |
| 2021 | -2.24x | $-215.71 Million | $96.27 Million | ▲ +1.0% |
| 2020 | -2.26x | $-177.98 Million | $78.63 Million | ▼ -220.5% |
| 2019 | -0.71x | $-97.85 Million | $138.55 Million | ▲ +57.7% |
| 2018 | -1.67x | $-73.55 Million | $44.08 Million | ▼ -18.1% |
| 2017 | -1.41x | $-63.21 Million | $44.75 Million | ▼ -13.6% |
| 2016 | -1.24x | $-62.56 Million | $50.33 Million | ▼ -278.8% |
| 2015 | -0.33x | $-12.44 Million | $37.91 Million | ▲ +77.7% |
| 2014 | -1.47x | $-29.82 Million | $20.25 Million | ▼ -238.8% |
| 2013 | -0.43x | $-15.38 Million | $35.38 Million | ▲ +80.0% |
| 2012 | -2.17x | $-22.31 Million | $10.28 Million | ▼ -45.5% |
| 2011 | -1.49x | $-19.76 Million | $13.24 Million | ▼ -12.0% |
| 2010 | -1.33x | $-11.94 Million | $8.97 Million | ▼ -83.9% |
| 2009 | -0.72x | $-14.08 Million | $19.44 Million | ▼ -29.4% |
| 2008 | -0.56x | $-11.13 Million | $19.88 Million | ▲ +57.5% |
| 2007 | -1.32x | $-11.51 Million | $8.74 Million | ▼ -132.8% |
| 2006 | -0.57x | $-7.04 Million | $12.45 Million | ▲ +74.7% |
| 2005 | -2.24x | $-12.34 Million | $5.51 Million | ▼ -77.9% |
| 2004 | -1.26x | $-6.80 Million | $5.40 Million | ▲ +45.9% |
| 2003 | -2.33x | $-2.75 Million | $1.18 Million | ▲ +20.5% |
| 2002 | -2.93x | $-4.96 Million | $1.69 Million | ▲ +41.6% |
| 2001 | -5.01x | $-8.37 Million | $1.67 Million | ▲ +9.0% |
| 2000 | -5.51x | $-8.79 Million | $1.60 Million | ▼ -90.7% |
| 1999 | -2.89x | $-6.30 Million | $2.18 Million | ▲ +31.2% |
| 1998 | -4.20x | $-6.30 Million | $1.50 Million | — |